TLS Beta Pte. Ltd.
Related Filers (12)
- Temasek Holdings (Private) Ltd (10)
- Fullerton Management Pte Ltd (10)
- Temasek Life Sciences Private Ltd (10)
- Intellia Therapeutics, Inc. (2)
- Homology Medicines, Inc. (2)
- Guardant Health, Inc. (2)
- Vir Biotechnology, Inc. (2)
- V-Sciences Investments Pte Ltd (2)
- Elbrus Investments Pte. Ltd. (1)
- Pear Therapeutics, Inc. (1)
- Akili, Inc. (1)
- Gracell Biotechnologies Inc. (1)
- Show More ...
Other (22)
13F-NT
Wednesday, 2/14/2024
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Tuesday, 11/14/2023
Initial Quarterly Form 13F Notice Report filed by institutional managers
144
Thursday, 10/12/2023
Filing for proposed sale of securities under Rule 144
13F-NT
Monday, 8/14/2023
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 5/15/2023
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Tuesday, 2/14/2023
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 11/14/2022
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 8/15/2022
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 5/16/2022
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 2/14/2022
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 11/15/2021
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 8/16/2021
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 5/17/2021
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Tuesday, 2/16/2021
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 11/16/2020
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Friday, 8/14/2020
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Friday, 5/15/2020
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Friday, 2/14/2020
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Thursday, 11/14/2019
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Wednesday, 8/14/2019
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Wednesday, 5/15/2019
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Thursday, 2/14/2019
Initial Quarterly Form 13F Notice Report filed by institutional managers
Ownership (10)
3
Friday, 8/26/2022
Akili, Inc.: Initial statement of beneficial ownership of securities
3
Thursday, 12/9/2021
Pear Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Friday, 10/18/2019
Vir Biotechnology, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 10/10/2019
Vir Biotechnology, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 10/11/2018
Guardant Health, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 10/3/2018
Guardant Health, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 4/4/2018
Homology Medicines, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 3/28/2018
Homology Medicines, Inc.: Initial statement of beneficial ownership of securities
4
Friday, 5/13/2016
Intellia Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 5/5/2016
Intellia Therapeutics, Inc.: Initial statement of beneficial ownership of securities